SB380 would create a new, limited licensing pathway for internationally trained physicians to practice medicine in Maryland. Beginning October 1, 2028, the State Board of Physicians could issue a license to a physician who was licensed outside the United States, its territories or possessions, Puerto Rico, or Canada, if the applicant meets a detailed set of education, training, examination, character, language, and verification requirements. The bill requires, among other things, a medical degree from a recognized foreign medical school, at least two years of postgraduate training equivalent to an accredited residency, recent practice experience, a valid ECFMG certificate, passing scores on all three steps of the USMLE, Maryland domicile, English proficiency, and good moral character.
The license created by the bill would be temporary and nonrenewable, with a maximum term of three years. The Board could deny eligibility based on prior discipline or competency problems during postgraduate training, and could revoke the license if the physician practices outside the license’s scope, loses employment, becomes the subject of discipline, or otherwise no longer qualifies. The Board would also be required to adopt regulations setting minimum qualifications, fees, conditions of practice, and a pathway to full licensure after the licensee satisfies board-imposed conditions. The bill takes effect October 1, 2026, but the licensing authority itself does not begin until October 1, 2028.
The bill’s impact would be to amend the Health Occupations Article by adding a new section governing licensure of internationally trained physicians. It would expand the pool of physicians potentially eligible to practice in Maryland while preserving substantial screening and oversight by the State Board of Physicians. The measure would affect foreign-trained doctors seeking Maryland licensure, the Board’s regulatory authority, and potentially patients and employers in areas facing physician shortages.
The general sentiment reflected by the bill text is supportive of expanding access to medical licensure for qualified internationally trained physicians, while maintaining strict safeguards. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of debate or formal support/opposition in the available materials. The structure of the bill suggests an intent to balance workforce expansion with patient safety and regulatory control.
Notable points of contention likely center on how rigorous the pathway should be and how much discretion the Board should have in determining eligibility, setting fees, and defining conditions for eventual full licensure. Potential concerns include whether the three-year, nonrenewable license is too restrictive, whether the USMLE and training requirements are too demanding for the intended population, and whether the bill sufficiently protects patients while addressing physician shortages. Supporters would likely emphasize workforce access, recognition of foreign credentials, and faster integration of experienced physicians into Maryland’s healthcare system.
SB380 would add new Section 14-321 to the Health Occupations Article, authorizing the State Board of Physicians to issue a limited, nonrenewable license to certain internationally trained physicians and requiring the Board to promulgate implementing regulations. It would not immediately change existing physician licensure rules for most applicants, but it would create a separate statutory pathway for foreign-licensed doctors who meet the bill’s criteria, including education, training, exam, language, and character requirements. The bill also gives the Board authority to set fees, impose practice conditions, revoke licenses under specified circumstances, and establish a route toward full licensure.
No committee testimony or vote record is provided, so there is no documented floor or committee sentiment to summarize. Based on the bill’s design, the measure appears generally favorable toward expanding physician access in Maryland, but with strong regulatory safeguards and oversight. The absence of recorded opposition or amendments in the supplied materials means the available evidence points only to the bill’s policy intent, not to any formal legislative consensus or controversy.
The main policy tensions are likely between expanding the physician workforce and maintaining high licensure standards. Possible points of contention include the requirement for USMLE Step 1, Step 2, and Step 3 passage, the need for two years of postgraduate training, and whether the Board should have broad discretion to deny applicants based on prior discipline or training issues. Another likely issue is the temporary, nonrenewable nature of the license and whether the bill provides a realistic pathway to full licensure. Supporters would likely prioritize workforce shortages and credential recognition, while skeptics may focus on patient safety, equivalency of foreign training, and the scope of Board authority.